Novel approach to restrict genetic-engineered therapies to malignant tissues

Novel approach to restrict genetic-engineered therapies to malignant tissues
Selective allosteric ABL1 inhibitor as a potential therapeutic agent for the treatment of leukemia
Gut bacteria as a potential chemotherapeutic carrier for brain cancer treatment